The goal of this activity is for clinicians to be better able to understand the role of hypoxia-inducible factor prolyl-hydroxylase inhibitors (HIF-PHIs) for the treatment of patients with dialysis-dependent (DD)-CKD anemia.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001551
- Start Date: 2024-09-12 05:00:00
- End Date: 2024-09-12 05:00:00
- Credit Details: IPCE Credits: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours - MOC Credit Details: ABIM - 0.25 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Akebia Therapeutics, Inc. - Amount: 0.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Internal Medicine, Nephrology
Subscribe
Login
0 Comments
Oldest